Table of contents
Editorial
The twain shall meet - p869
doi:10.1038/nbt1009-869
Announcing an initiative to connect commercially oriented academics with their local business community.
Abstract - | Full Text - The twain shall meet | PDF (100 KB) - The twain shall meet
News
Expanded access rules pose quandary for drug developers - pp871 - 872
George S Mack
doi:10.1038/nbt1009-871
Full Text - Expanded access rules pose quandary for drug developers | PDF (328 KB) - Expanded access rules pose quandary for drug developers
FDA penalizes trial misconduct - p872
Catherine Shaffer
doi:10.1038/nbt1009-872
Full Text - FDA penalizes trial misconduct | PDF (122 KB) - FDA penalizes trial misconduct
Test tube meat on the menu? - p873
Jeffrey L Fox
doi:10.1038/nbt1009-873
Full Text - Test tube meat on the menu? | PDF (91 KB) - Test tube meat on the menu?
Europe plans for drug-making plants - p874
Wendy Wolfson
doi:10.1038/nbt1009-874a
Full Text - Europe plans for drug-making plants | PDF (143 KB) - Europe plans for drug-making plants
Pfizer lured to Sweden - p874
Susan Aldridge
doi:10.1038/nbt1009-874b
Full Text - Pfizer lured to Sweden | PDF (143 KB) - Pfizer lured to Sweden
Spotlight focuses on protein-misfolding therapies - p874
Mark Ratner
doi:10.1038/nbt1009-874c
Full Text - Spotlight focuses on protein-misfolding therapies | PDF (143 KB) - Spotlight focuses on protein-misfolding therapies
Regulation of consumer genomic tests remains in limbo - pp875 - 877
Malorye Allison
doi:10.1038/nbt1009-875
Full Text - Regulation of consumer genomic tests remains in limbo | PDF (184 KB) - Regulation of consumer genomic tests remains in limbo
Golden Triangle taps Boston - p877
Susan Aldridge
doi:10.1038/nbt1009-877a
Full Text - Golden Triangle taps Boston | PDF (87 KB) - Golden Triangle taps Boston
Fits and starts for Geron - p877
Laura DeFrancesco
doi:10.1038/nbt1009-877b
Full Text - Fits and starts for Geron | PDF (87 KB) - Fits and starts for Geron
Firms seek new models to access public equity - pp878 - 879
Peter Mitchell
doi:10.1038/nbt1009-878
Full Text - Firms seek new models to access public equity | PDF (271 KB) - Firms seek new models to access public equity
Sanofi's Shantha boost - p879
Killugudi Jayaraman
doi:10.1038/nbt1009-879a
Full Text - Sanofi's Shantha boost | PDF (104 KB) - Sanofi's Shantha boost
Gulf beckons biotech - p879
Hayley Birch
doi:10.1038/nbt1009-879b
Full Text - Gulf beckons biotech | PDF (104 KB) - Gulf beckons biotech
News Feature
Under wraps - pp880 - 882
Emily Waltz
doi:10.1038/nbt1009-880
Are the crop industry's strong-arm tactics and close-fisted attitude to sharing seeds holding back independent research and undermining public acceptance of transgenic crops? Emily Waltz investigates.
Abstract - | Full Text - Under wraps | PDF (406 KB) - Under wraps
Bioentrepreneur
Building a business
Credibility: your most important asset - pp883 - 885
Douglas MacDougall & Jennifer Conrad
doi:10.1038/bioe.2009.8
Opinion and Comment
Correspondence
Is it virtuous to be virtual? The VC viewpoint - pp886 - 888
Justin Chakma, Jeff L Calcagno, Ali Behbahani & Shawn Mojtahedian
doi:10.1038/nbt1009-886
Full Text - Is it virtuous to be virtual? The VC viewpoint | PDF (236 KB) - Is it virtuous to be virtual? The VC viewpoint | Supplementary information
The power of social networking in medicine - pp888 - 890
Catherine A Brownstein, John S Brownstein, David S Williams III, Paul Wicks & James A Heywood
doi:10.1038/nbt1009-888
Full Text - The power of social networking in medicine | PDF (357 KB) - The power of social networking in medicine
Creating a mouse academic research commons - pp890 - 891
David Einhorn & Rita Heimes
doi:10.1038/nbt1009-890
Full Text - Creating a mouse academic research commons | PDF (105 KB) - Creating a mouse academic research commons
Cofactor-mediated protein promiscuity - p892
Jordan D Dimitrov & Tchavdar L Vassilev
doi:10.1038/nbt1009-892a
Full Text - Cofactor-mediated protein promiscuity | PDF (270 KB) - Cofactor-mediated protein promiscuity
Healthcare-biotech symbiosis - pp892 - 893
Kamran Ahmed & Hutan Ashrafian
doi:10.1038/nbt1009-892b
Full Text - Healthcare-biotech symbiosis | PDF (337 KB) - Healthcare-biotech symbiosis
Improved genome annotation for Zymomonas mobilis - pp893 - 894
Shihui Yang, Katherine M Pappas, Loren J Hauser, Miriam L Land, Gwo-Liang Chen, Gregory B Hurst, Chongle Pan, Vassili N Kouvelis, Milton A Typas, Dale A Pelletier, Dawn M Klingeman, Yun-Juan Chang, Nagiza F Samatova & Steven D Brown
doi:10.1038/nbt1009-893
Full Text - Improved genome annotation for Zymomonas mobilis | PDF (162 KB) - Improved genome annotation for Zymomonas mobilis | Supplementary information
Features
Can web 2.0 reboot clinical trials? - pp895 - 902
Malorye Allison
doi:10.1038/nbt1009-895
Dozens of companies are trying to leverage social networking and other software tools to accelerate trials and reduce their cost.
Abstract - | Full Text - Can web 2.0 reboot clinical trials? | PDF (494 KB) - Can web 2.0 reboot clinical trials?
Patents
Legal uncertainty in the area of genetic diagnostic testing - pp903 - 909
Isabelle Huys, Nele Berthels, Gert Matthijs & Geertrui Van Overwalle
doi:10.1038/nbt1009-903
A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.
Abstract - | Full Text - Legal uncertainty in the area of genetic diagnostic testing | PDF (266 KB) - Legal uncertainty in the area of genetic diagnostic testing | Supplementary information
Recent patent applications in RNA interference - p910
doi:10.1038/nbt1009-910
Full Text - Recent patent applications in RNA interference | PDF (48 KB) - Recent patent applications in RNA interference
News and Views
siRNA delivery not Toll-free - pp911 - 912
Michael P Gantier & Bryan R G Williams
doi:10.1038/nbt1009-911
Activating the tumor-associated immune system with an siRNA conjugated to a Toll-like receptor 9 ligand is a promising anticancer strategy.
Full Text - siRNA delivery not Toll-free | PDF (1,116 KB) - siRNA delivery not Toll-free
See also: Research by Kortylewski et al.
Snapshots of kinase activities - pp912 - 913
Javier Muñoz & Albert J R Heck
doi:10.1038/nbt1009-912
A mass spectrometry–based strategy facilitates sensitive and rapid detection of kinase activities in small amounts of cell lysate.
Full Text - Snapshots of kinase activities | PDF (248 KB) - Snapshots of kinase activities
See also: Research by Kubota et al.
Stem cell biology meets p53 - pp914 - 915
Anna M Puzio-Kuter & Arnold J Levine
doi:10.1038/nbt1009-914
Often called "the guardian of the genome," p53 may also be the guardian of stable development.
Full Text - Stem cell biology meets p53 | PDF (179 KB) - Stem cell biology meets p53
Cancer's insatiable appetite - pp916 - 917
Jason W Locasale, Lewis C Cantley & Matthew G Vander Heiden
doi:10.1038/nbt1009-916
Seemingly unrelated mutations that drive cancer share the ability to promote nutrient uptake and metabolism conducive to cell growth.
Full Text - Cancer's insatiable appetite | PDF (154 KB) - Cancer's insatiable appetite
Introducing the acetylome - pp917 - 919
Karen T Smith & Jerry L Workman
doi:10.1038/nbt1009-917
Mass spectrometry reveals protein acetylation to be as widespread as phosphorylation.
Full Text - Introducing the acetylome | PDF (164 KB) - Introducing the acetylome
Research Highlights
Research highlights - p920
Kathy Aschheim, Markus Elsner, Peter Hare & Craig Mak
doi:10.1038/nbt1009-920
Full Text - Research highlights | PDF (193 KB) - Research highlights
Computational Biology
Primer
How to visually interpret biological data using networks - pp921 - 924
Daniele Merico, David Gfeller & Gary D Bader
doi:10.1038/nbt.1567
Networks in biology can appear complex and difficult to decipher. Merico et al. illustrate how to interpret biological networks with the help of frequently used visualization and analysis patterns.
Abstract - | Full Text - How to visually interpret biological data using networks | PDF (355 KB) - How to visually interpret biological data using networks
Research
Articles
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses - pp925 - 932
Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann, Lin Wang, Claudia Kowolik, Maciej Kujawski, Heehyoung Lee, Anna Scuto, Yong Liu, Chunmei Yang, Jiehui Deng, Harris S Soifer, Andrew Raubitschek, Stephen Forman, John J Rossi, Drew M Pardoll, Richard Jove & Hua Yu
doi:10.1038/nbt.1564
Tumors generate microenvironments that actively suppress the body's anti-tumor immune response. Kortylewski et al. restore immunity by delivering an siRNA against Stat3, a regulator of immune suppression, to myeloid and B cells using a CpG oligonucleotide that targets toll-like receptor 9.
Abstract - | Full Text - In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses | PDF (1,185 KB) - In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses | Supplementary information
See also: News and Views by Gantier & Williams
Sensitive multiplexed analysis of kinase activities and activity-based kinase identification - pp933 - 940
Kazuishi Kubota, Rana Anjum, Yonghao Yu, Ryan C Kunz, Jannik N Andersen, Manfred Kraus, Heike Keilhack, Kumiko Nagashima, Stefan Krauss, Cloud Paweletz, Ronald C Hendrickson, Adam S Feldman, Chin-Lee Wu, John Rush, Judit Villén & Steven P Gygi
doi:10.1038/nbt.1566
Kubota et al. describe a sensitive mass spectrometric method for generating signatures of kinase activity characteristic of specific cell types. They also identify kinases responsible for phosphorylating substrates of interest.
Abstract - | Full Text - Sensitive multiplexed analysis of kinase activities and activity-based kinase identification | PDF (823 KB) - Sensitive multiplexed analysis of kinase activities and activity-based kinase identification | Supplementary information
See also: News and Views by Muñoz & Heck
Letters
Induction of protein-protein interactions in live cells using light - pp941 - 945
Masayuki Yazawa, Amir M Sadaghiani, Brian Hsueh & Ricardo E Dolmetsch
doi:10.1038/nbt.1569
Controlling protein-protein interaction with high temporal and spatial resolution is essential for understanding many cellular processes. Yazawa et al. present genetically encoded tags that can induce protein dimer formation upon stimulation with blue light.
First Paragraph - | Full Text - Induction of protein-protein interactions in live cells using light | PDF (1,362 KB) - Induction of protein-protein interactions in live cells using light | Supplementary information
Automated design of synthetic ribosome binding sites to control protein expression - pp946 - 950
Howard M Salis, Ethan A Mirsky & Christopher A Voigt
doi:10.1038/nbt.1568
Salis et al. design precisely tuned ribosome binding sites that allow rational control over the rate of protein translation. This technology should facilitate the design of synthetic genetic circuits and metabolic pathways.
First Paragraph - | Full Text - Automated design of synthetic ribosome binding sites to control protein expression | PDF (532 KB) - Automated design of synthetic ribosome binding sites to control protein expression | Supplementary information
A proteomics approach to discovering natural products and their biosynthetic pathways - pp951 - 956
Stefanie B Bumpus, Bradley S Evans, Paul M Thomas, Ioanna Ntai & Neil L Kelleher
doi:10.1038/nbt.1565
Nonribosomal peptides and polyketides constitute a large fraction of antibiotic, antitumor and immunosuppressant drugs. Bumpus et al. present a proteomic strategy to identify new natural products and their biosynthetic pathways.
First Paragraph - | Full Text - A proteomics approach to discovering natural products and their biosynthetic pathways | PDF (799 KB) - A proteomics approach to discovering natural products and their biosynthetic pathways | Supplementary information
Errata
Erratum: Sanofi Aventis grooms its ranks for biotech partnering - p957
Nuala Moran
doi:10.1038/nbt1009-957a
Full Text - Erratum: Sanofi Aventis grooms its ranks for biotech partnering | PDF (55 KB) - Erratum: Sanofi Aventis grooms its ranks for biotech partnering
Erratum: Diagnostics firms face new patent claim worries - p957
Malorye Allison
doi:10.1038/nbt1009-957b
Full Text - Erratum: Diagnostics firms face new patent claim worries | PDF (55 KB) - Erratum: Diagnostics firms face new patent claim worries
Erratum: Novo awaits green light for diabetes drug - p957
Mike May
doi:10.1038/nbt1009-957c
Full Text - Erratum: Novo awaits green light for diabetes drug | PDF (55 KB) - Erratum: Novo awaits green light for diabetes drug



